Press Release

Press Releases

Veriskin is at the forefront of the most accurate skin cancer screening technology. Here you can find out what the company is up to.

Press Release

Veriskin Receives Special Invitation to LA BioMed Innovation Showcase 2018

Effective date:

Veriskin, Inc. scored top among 13 medical device companies selected to participate in LA BioMed Innovation Showcase 2018.


Veriskin Initiates 100+ Patient Clinical Study

Effective date:

Veriskin, Inc. has initiated a 100+ human clinical study to test the TruScore device. The IRB approved study is conducted by Palo Alto Medical Foundation (a division of Sutter Health).


Veriskin Invited to Present at TedX San Diego Innovation Alley

Effective date:

Veriskin, Inc. was invited to present at TedXs' Innovation Alley held in downtown San Diego that showecased 20 of San Diego’s most innovative companies and entrepreneurs. See event photos here.




Veriskin Receives NIH Grant to Pursue Skin Cancer Screening Technology

Effective date:

Veriskin, Inc. has been awarded s $1.875M grant by the National Institutes of Health to develop a novel technology for non-invasive skin cancer screening. The National Cancer Institute that issued the award cited “the exceptionally high impact that the proposed device is expected to make in the field of non-invasive skin cancer diagnostics”.